|
FY2024
12 months to Sep 30, 2025
|
FY2023
12 months to Sep 30, 2024
|
FY2022
12 months to Sep 30, 2023
|
FY2021
12 months to Sep 30, 2022
|
FY2020
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Net income (loss) | |||||
| Bad debt expense | |||||
| Trade Accounts Receivable | |||||
| Total bad debt expense | |||||
| Deferred financing cost amortization | |||||
| Depreciation and amortization | |||||
| Loss (gain) on sale of assets | |||||
| Non-cash compensation | |||||
| Deferred income taxes | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Costs and estimated earnings in excess of billings | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable and accrued expenses | |||||
| Billings in excess of costs and estimated earnings | |||||
| Other non-current liabilities | |||||
| Net cash provided by operating activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of assets | |||||
| Payments to Acquire Equity Method Investments | |||||
| Cash received (paid) in conjunction with business combinations | |||||
| Net cash used in investing activities | |||||
| Borrowings of debt | |||||
| Repayments of debt | |||||
| Finance lease payment | |||||
| Payment for Contingent Consideration Liability, Financing Activities | |||||
| Payments for Repurchase of Redeemable Noncontrolling Interest | |||||
| Distribution to noncontrolling interests | |||||
| Purchase of treasury stock | |||||
| Issuance of shares | |||||
| Net cash used in financing activities | |||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| CASH, CASH EQUIVALENTS and RESTRiCTED CASH, beginning of period | |||||
| CASH, CASH EQUIVALENTS and RESTRICTED CASH, end of period | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes (net) | |||||
Loading...